Physician profile
Sierra Olson
NPI 1588244081
$4,019.29
in general payments reported to CMS, 2019-2025
20 companies · $1,326 in 2025
The $1,326 reported for 2025 was more than what 87% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $19.69 · 2022: $216 · 2023: $1,242 · 2024: $1,215 · 2025: $1,326.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,783.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,783.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $976.61 | 2022-2025 | Wegovy, Ozempic, Rybelsus |
| Exeltis, USA INC. | $713.18 | 2023-2025 | Slynd, Twirla |
| Mayne Pharma Commercial LLC | $377.00 | 2023-2025 | |
| Biogen, INC. | $355.73 | 2024-2025 | Zurzuvae |
| Astellas Pharma US INC | $294.70 | 2023-2025 | Veozah |
| Millicent US INC | $287.66 | 2023-2025 | Intrarosa, Femlyv |
| Axonics, INC. | $231.37 | 2023-2024 | Axonics, Bulkamid |
| Organon LLC | $143.32 | 2023-2024 | Nexplanon |
| Shield Therapeutics INC | $104.48 | 2024-2025 | |
| Coloplast Corp | $101.74 | 2023-2025 | Saffron |
| Avion Pharmaceuticals | $90.90 | 2023 | Balcoltra |
| Stryker Corporation | $75.21 | 2022 | |
| Idorsia Pharmaceuticals US INC | $65.30 | 2023 | Quviviq |
| Exact Sciences Corporation | $49.62 | 2023-2025 | Cologuard Collection Kit |
| Evofem Biosciences, INC. | $45.43 | 2024 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ascend Therapeutics US, LLC | $26.66 | 2023 | |
| Aspira Women'S Health INC | $24.73 | 2024 | Ova1 |
| Lilly USA, LLC | $19.69 | 2021 | |
| Sumitomo Pharma America, INC. | $18.07 | 2024 | Myfembree |
| Acella Pharmaceuticals, LLC | $17.89 | 2025 | NP Thyroid 60 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sierra Olson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.